CPSE:DEMANTMedical Equipment
Can Demant (CPSE:DEMANT) Be Revalued As Earnings Improve And Oticon Reveal Launches?
Why Demant’s latest earnings and product launch matter for investors
Demant (CPSE:DEMANT) has just paired half year 2026 earnings, with higher sales and net income, and launched Oticon Reveal, a new AI powered rechargeable hearing aid, putting both financial and product performance in focus.
See our latest analysis for Demant.
At a share price of DKK286.0, Demant has seen a 15.70% 90 day share price return and a 34.02% year to date share price return, while the 5 year total shareholder return...